Structures of enzymatically modified products of arbekacin by methicillin-resistant Staphylococcus aureus.
スポンサーリンク
概要
- 論文の詳細を見る
Only a limited number of strains of methicillin-resistant Staphylococcus aureus (MRSA) moderately resistant to arbekacin (ABK) have been isolated clinically. Three inactivated products of ABK have been obtained by reaction with excess amounts of a crude enzyme preparation extracted from an ABK-resistant MRSA strain (MIC, 25μg/ml). The 2''-O-phosphate was the major product together with small amounts of the 6'-N-acetate and the double modification product. The structures of these modification products were determined by MS and NMR spectral analyses.
- 公益財団法人 日本感染症医薬品協会の論文
公益財団法人 日本感染症医薬品協会 | 論文
- Purification and properties of pepstatin hydrolase from Bacillus sphaericus.
- KS-504 compounds, novel inhibitors of Ca2+ and calmodulin-dependent cyclic nucleotide phosphodiesterase from mollisia ventosa.
- K-252b, c and d, potent inhibitors of protein kinase C from microbial origin.
- ROSEOFLAVIN, A NEW ANTIMICROBIAL PIGMENT FROM STREPTOMYCES
- Tetrazomine, a new antibiotic produced by an actinomycete strain. Taxonomy, fermentation, isolation and characterization.:TAXONOMY, FERMENTATION, ISOLATION AND CHARACTERIZATION